In vitro study on the effects of bradykinin potentiating factor and angiotensin II analogue on degradation and conversion of angiotensin I and II in plasma.
D000804:Angiotensin II / Q000097:blood* / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001920:Bradykinin / Q000378:metabolism*; D003429:Cross Reactions; D006801:Humans; D010455:Peptides / Q000494:pharmacology*; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D011863:Radioimmunoassay; D012911:Snakes; D013329:Structure-Activity Relationship; D013997:Time Factors; D014688:Venoms / Q000494:pharmacology
D000806:Angiotensin-Converting Enzyme Inhibitors; D010455:Peptides; D014688:Venoms; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A; D001920:Bradykinin